MMP9 and carcinoma: There are reports in the fields of ESCC [22,23,25], oral squamous cell [44], gastric [45], breast [46], and bladder [47] carcinomas that suggest MMP9 expression in cancer cells is significantly related to poor clinical outcomes including patient survival or lymph node metastases.